IMCA
LIVE

Serial Number

79375787

Owner

PRECIPHOS

Attorney

R. Peter Spies

Filing Date

May 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMCA Trademark

Serial Number: 79375787 • Registration: 7484102

IMCA is a trademark filed by PRECIPHOS on May 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

PRECIPHOS

8 place de l'hôpital

Entity Type: 34

Trademark Details

Filing Date

May 5, 2023

Registration Date

August 27, 2024

Published for Opposition

June 11, 2024

Goods & Services

Arrays of filtering microwells for the analysis of complex bio-molecules for medical use in human or veterinary medicine; biological preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; chemical preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; pharmaceutical preparations for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases, in oncology or inflammatory diseases; chemical reagents for medical and pharmacological use; diagnostic biomarker reagents for medical use and conducting pharmacology studies

Medical apparatus for analysis, diagnosis and prognosis for medical use for treatment of cardiovascular diseases, for use in oncology, for use infectiology or inflammatory diseases in human or veterinary medicine; medical apparatus for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases; analysis, diagnosis and prognosis devices for medical use and medical research; medical devices for analysis, diagnosis and prognosis of cardiovascular diseases; medical devices, namely, analytical devices for medical use in biomarker identification; portable analysis devices for in vitro diagnosis for medical use or medical research or medicine production; clinical chemistry analyzers of complex bio-molecules and autoimmune and inflammatory-related biomarkers for medical use; medical device in the nature of analysis device for medical use based on miniaturized immunological technology for treatment of cardiovascular diseases, infectious diseases, oncology, autoimmune diseases or inflammatory diseases.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 2, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 1, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2024 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 4, 2024 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 4, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 4, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 4, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 4, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 4, 2024 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 4, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 9, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 8, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2023 REPR